Most COVID-19 vaccine candidates rely on the S protein as their antigen, since this is the primary exposed protein on the surface of the SARS-CoV-2 viral particle, and β-propiolactone is used as the inactivation reagent. The gene discussed is PROS1; the disease is COVID-19.